Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased 7% year over ...

U.S. pharmaceutical giant Merck has warned that existing tariffs imposed by the Trump administration will cost the company an ...

Switzerland’s president is lobbying Trump administration officials in Washington this week, as concern mounts over the double ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Merck, Bristol Myers Squibb, Sanofi and Roche had little clarity on the potential impact of President Donald Trump’s ...

Swiss pharma giant Roche (ROG: SIX) today reported that it achieved sales growth of 6% (7% in francs) to 15.4 billion francs ...

The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

Sanofi (SNY) stock and Roche (RHHBY) stock trade flat after the duo reaffirmed 2025 forecasts despite strong Q1 results. Read ...

Businesses across multiple industries are increasing prices, cutting financial guidance and warning of growing uncertainty as ...

The pharmaceutical and diagnostics company slightly exceeded expectations in the first quarter, driven by its pharmaceutical ...

Roche has said it is petitioning the Trump administration for an exemption from threatened tariffs for pharmaceuticals, ...